Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
35.1%
% of BHCHX's 40 holdings also in GDOC
31.7%
% of GDOC's 43 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BHCHX |
Weight in GDOC |
Overlap | |
---|---|---|---|---|
ELI LILLY AND COMPANY | 9.3% | 10.4% | 9.3% | |
BOSTON SCIENTIFIC CORPORATION | 5.3% | 5.9% | 5.3% | |
INTUITIVE SURGICAL, INC. | 5.8% | 5.0% | 5.0% | |
THE COOPER COMPANIES, INC. | 2.6% | 3.3% | 2.6% | |
DANAHER CORPORATION | 1.9% | 3.8% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to GDOC
UNITEDHEALTH GROUP INCORPORATED | 7.3% | |
MERCK & CO., INC. | 4.8% | |
THERMO FISHER SCIENTIFIC INC | 4.7% | |
VERTEX PHARMACEUTICALS INCORPORATED | 4.6% | |
STRYKER CORPORATION | 3.2% | |
ICON PLC | 3.2% | |
ELEVANCE HEALTH, INC. | 2.7% | |
MCKESSON CORPORATION | 2.7% | |
ARCELLX, INC. | 2.6% | |
ARGENX SE ADR | 2.4% |
BHCHX Underweight Relative to GDOC
ASTRAZENECA PLC | -6.2% | |
NOVO NORDISK A/S-B | -5.8% | |
ABBVIE INC | -4.7% | |
AMGEN INC | -4.6% | |
NEUROCRINE BIOSCIENCES INC | -3.4% | |
INSULET CORP | -3.4% | |
HUMANA INC | -3.4% | |
ABBOTT LABORATORIES | -3.1% | |
CSL LIMITED | -3.0% | |
BIOMARIN PHARMACEUTICAL INC | -3.0% |